Thank you, healthcare workers, for all you do. Your determination to help others is truly inspiring. Please stay safe.

Course Listings: Oncology

All Results (8)
Format: Live Events (0) Online Activities (8)

Decision Making in Advanced NSCLC: The Community Physician Perspective on Immunotherapy

View Course

Format: E-Publication

Maximum Credits: 1.0

Course Description: This accredited CME activity reviews the clinical evidence around immunotherapy for the treatment of advanced non–small cell lung cancer (NSCLC), including immune checkpoint inhibitor (ICI) monotherapy, chemoimmunotherapy, dual ICI therapy, and quadruple drug regimens, as well as the current role of predictive biomarkers in treatment selection. Special…More


Targeted Therapy in Cholangiocarcinoma: Focus on FGFR Inhibitors

View Course

Format: E-Publication

Maximum Credits: 0.75

Course Description: This online, accredited CME publication explores emerging clinical data and insights related to the potential use of fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinoma. It addresses the challenges and limitations of emerging FGFR inhibitors, discusses current research on using genomic biomarkers and their potential to predict response to…More


Therapeutic Advances in Relapsed/Refractory DLBCL: A Focus on Emerging Agents

View Course

Format: Med-IQ Express

Maximum Credits: 0.25

Course Description: This brief accredited CME/CE activity reviews the latest clinical research and potential implications of select novel treatment strategies undergoing evaluation in clinical trials in relapsed/refractory diffuse large B-cell lymphoma (DLBCL). In addition, this activity features a short video that provides expert commentary from Jia Ruan, MD, PhD, on how these…More


Therapeutic Advances in Relapsed/Refractory DLBCL: A Focus on Newly Available Treatment Strategies

View Course

Format: Med-IQ Express

Maximum Credits: 0.25

Course Description: This brief accredited CME/CE publication explores the cutting-edge evidence regarding newly available treatment strategies in relapsed/refractory diffuse large B-cell lymphoma (DLBCL) and discusses how these data affect routine practice. In addition, this activity features a short video that provides expert commentary from Christopher Flowers, MD, on how he…More


Decision-IQ: Management of HER2-Positive Breast Cancer With Brain Metastases: A Case-Based Activity

View Course

Format: Decision-IQ

Maximum Credits: 0.25

Course Description: In this brief, case-based activity, meet a 42-year-old woman with a history of human epidermal growth factor 2 (HER2)-positive breast cancer that metastasized to the brain while she was receiving systemic therapy. As you move through this activity, you will:Be directed to useful resources to help you make clinical decisions about managing her systemic and…More


The Arrival of CAR T-Cell Therapy—Exploring the Latest Advances and Impact on Patient Care

View Course

Format: E-Publication

Maximum Credits: 1.0

Course Description: This online publication explores the role of CAR T-cell therapy in the treatment of hematologic malignancies, the administration process of this therapy, and current and emerging clinical evidence on approved and investigational agents. Clinical cases and practical strategies are provided to incorporate expert insights on patient selection and the recognition…More


The Promise of FGFR Inhibitors in Cholangiocarcinoma: Are You Prepared?

View Course

Format: Med-IQ Select

Maximum Credits: 0.5

Course Description: This modular, accredited CME publication explores emerging research and practical insights related to the potential use of FGFR inhibitors in cholangiocarcinoma. Audio clips provide insights from expert faculty, Lipika Goyal, MD, MPhil, on the role of FGFR in cholangiocarcinoma pathogenesis and FGFR inhibitors that are currently in development, as well as…More


A New Era in TGCT Treatment: Novel Targeted Therapies and Their Effect on Shared Decision Making

View Course

Format: E-Publication

Maximum Credits: 0.75

Course Description: This accredited CME publication explores the latest therapeutic advances and emerging science for the management of tenosynovial giant cell tumor (TGCT). In addition to discussing the safety and efficacy of recently approved and emerging therapies, it also addresses how to implement the principles of shared decision making in the routine care of patients with…More




We recently updated our Privacy Notice and Terms of Use.